Diseases & Disorders
(G81Z)
IRS Verified
DX Registered
990 on File
AIDS LEGAL REFERRAL PANEL OF THE SAN FRANCISCO BAY AREA
Financial strength (30%)
79/100
Reliability (20%)
55/100
Effectiveness (25%)
85/100
Impact (25%)
No data yet
CharityAI™ Score
Not yet evaluated
Financial Overview — FY 2025
$2.8M
Total Revenue
$2.8M
Total Expenses
$1.8M
Net Assets
33
Employees
Revenue Sources
Expense Breakdown
Program Expense Ratio
83.2%
Fundraising Efficiency
406.7%
Operating Reserve
7.75x
Liability-to-Asset
40.9%
Revenue Diversification
99.9%
Executive Compensation
$175K
Compared with Peers
FY 2025
Compared with 336 similar organizations
(United States, Diseases & Disorders, $1M–$10M in expenses), FY 2025.
This organization
Middle half of peers (P25–P75)
Peer median
| Ratio | This org | Peer median | Position (P10 → P90) | |
|---|---|---|---|---|
|
Program expense ratio
Program expenses / total expenses
· higher is better
|
83.2% | 82.1% |
P10P90
|
Above median |
|
Admin expense ratio
Management and general / total expenses
· lower is better
|
9.3% | 11.1% |
P10P90
|
Above median |
|
Fundraising expense ratio
Fundraising expenses / total expenses
· lower is better
|
7.4% | 3.1% |
P10P90
|
Below median |
|
Fundraising efficiency
Fundraising expenses / gross fundraising income
· lower is better
|
406.7% | 114.8% |
P10P90
|
Bottom quarter |
|
Operating reserve
Months of expenses covered by net assets
· higher is better
|
7.8 mo | 12.8 mo |
P10P90
|
Below median |
|
Liabilities to assets
Total liabilities / total assets
· lower is better
|
40.9% | 12.5% |
P10P90
|
Bottom quarter |
|
Revenue concentration
Share of revenue from the largest source
· lower is better
|
99.9% | 87.6% |
P10P90
|
Bottom quarter |
|
Revenue growth
Year over year revenue growth
|
7.4% | 6.7% |
P10P90
|
|
|
Expense growth
Year over year expense growth
|
4.6% | 6.5% |
P10P90
|
|
|
Surplus margin
Surplus as a share of revenue
|
0.9% | 3.9% |
P10P90
|
Financial History
| Year | Revenue | Expenses | Net Assets | Program % | Staff |
|---|---|---|---|---|---|
| 2025 | $2.8M | $2.8M | $1.8M | 83.2% | 33 |
| 2024 | $2.6M | $2.7M | $1.8M | 81.3% | 30 |
| 2023 | $2.4M | $2.5M | $1.8M | 83.0% | 32 |
| 2022 | $2.2M | $2.4M | $1.9M | 86.4% | 29 |
| 2021 | $4.8M | $2.2M | N/A | — | 32 |
Donor Reviews
Write a ReviewNo reviews yet
Be the first to share your experience with this organization.